… Factor XIa inhibitors for the prevention and treatment of venous and arterial … factor XIa
inhibition with milvexian was effective for preventing venous thromboembolism and was …

… Patients undergoing total knee arthroplasty are at high risk for postoperative venous
thromboembolism. Enoxaparin, an inhibitor of factor Xa and thrombin, is often administered …

… patients with venous thromboembolism who had undergone six months of anticoagulant
therapy to extended secondary prevention with the oral direct thrombin inhibitor ximelagatran (…

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-…

… In the milvexian twice daily arms, venous thromboembolism … milvexian once daily, venous
thromboembolism developed in 7 … for the prevention of venous thromboembolism, particularly …

… prevention of venous thrombosis target critical procoagulant proteins along this pathway
to inhibit their activity and prevent … Efforts to predict and prevent venous thromboembolic …

… In conclusion, administration of the partial FIXa inhibitor TTP889 started 6–10 days after …
prevention of VTE. Given that promising results have been obtained with other FIXa inhibitors in …

… FXII in the pathogenesis of venous thromboembolism, explain why FXI is … inhibitors under
development and discuss their potential to address unmet needs in venous thromboembolism …

… antagonists for prevention of venous thromboembolism in high-… absorption to the reversible
thrombin inhibitor dabigatran. It is … of enoxaparin for venous thromboembolism prophylaxis in …

… FXa inhibitor BAY 59-7939, at 2.5–10 mg bid, compared favorably with enoxaparin for the
prevention of venous thromboembolism in patients undergoing elective total hip replacement. …